π End of Day Bhavcopy
Date: 2025-09-09
Price: 248.04
% Change: 2.07% (Prev Close: 243.00)
Volume: 1,41,523
% Change: -38.65% (Prev Volume: 2,30,665)
Delivery: 67,055
Delivery % : 47.38
% Change: -34.87% (Prev Delivery: 1,02,948)
Turnover: 353 Lacs
% Change: -37.73% (Prev Turnover: 567)
πΉ EOD Valuation
P/E Ratio: 30.66
P/B Ratio: 3.27
Market Cap: 2200 Rs. Cr.
Fundamental Data
Date: 05-09-2025
π·οΈ Company Basics
Symbol: SMSPHARMA
Market Cap: 2100 Rs. Cr.
Face Value: 1.00 Rs.
52 Week High: 398.00
52 Week Low: 175.00
All-Time High: 398.00 Rs.
All-Time Low: 6.25 Rs.
Stock Price Increase (% Return) %
% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
5.72% | -4.60% | 17.56% | -31.51% | 42.18%
π₯ Shareholding Pattern
Promoter Holding
Promoter Holding: 66.26%
Change (3Y | 1Y): 2.08% | 0.00%
Pledged %: 37.60%
FII Holding
FII Holding: 0.03%
Change (3Y | 1Y): -0.60% | -0.05%
DII Holding
DII Holding: 3.03%
Change (3Y | 1Y): 3.03% | 0.60%
Public Holding: 30.68%
π¦ Financial Strength
Debt to Equity: 0.46
Debt: 310.75 Rs. Cr.
Book Value: 75.92 Rs.
Current Ratio: 1.71
Interest Coverage: 5.84
Free Cash Flow: -41.61 Rs. Cr.
π Growth & Sales
Sales Growth: 10.29%
Sales Growth Qtr (YOY | QoQ):
19.22% | -21.01%
Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.70% | 14.62% | 10.29%
π° Profit & Earnings
Profit Growth %
Profit Growth: 24.42%
Profit Growth Qtr (YOY | QoQ):
11.51% | -11.69%
Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
15.88% | 0.17% | 24.42%
EPS Rs.
EPS (TTM): 8.09 Rs.
EPS Qtr (Last Year | Latest):
1.93 Rs. | 2.05 Rs.
EPS Annual (Last Annual | Annual March):
5.83 Rs. | 7.71 Rs.
EPS Growth Variation % (5 Yrs | 3 Yrs):
14.83% | -1.34%
Net Profit Rs. Cr.
Net Profit (TTM): 70.26 Rs. Cr.
Net Profit (Annual - March): 68.38 Rs. Cr.
Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
16.33| 20.62 | 18.21
EBITDA Rs. Cr.
EBITDA (Quarter): 39.45 Rs. Cr.
EBITDA (Previous Yr Ql): 34.84 Rs. Cr.
EBITDA (Annual - March): 146.20 Rs. Cr.
EBITDA (Previous Annual): 121.41 Rs. Cr.
EBITDA (5 Yrs | 3 Yrs) %:
11.41% | 6.81%
π Profitability Ratios
Operating Margin (OPM)
OPM (TTM): 17.85%
OPM Qtr (Previous | Current):
16.66% | 19.82%
OPM Annual (5 Yrs | Last Yr | March):
17.68% | 16.49% | 17.88%
Return on Equity %
ROE: 11.00%
ROE (5 Yrs | 3 Yrs | Last Yr):
10.00% | 7.39% | 9.27%
Return on Capital Employed %
ROCE: 12.19%
ROCE (5 Yrs | 3 Yrs | Last Yr):
11.25% | 9.03% | 11.23%
Return on Assets %
ROA (TTM): 6.07%
ROA (5 Yrs | 3 Yrs | Last Yr):
5.56% | 3.84% | 4.98%
PEG Ratio: 175.76
Dividend Yield: 0.17%
PE 3 Yrs: 40.74
PE 5 Yrs: 29.49
Dividend Yield: 0.17%
π₯ Company
SMS Pharmaceuticals Ltd
SMSPHARMA
Promoter Holding: %